Close
Nordic 9Nordic 9

RAB Capital (investor - Others)

United Kingdom rabcap.com
See something wrong or missing? Let us know
Offices:London

 RAB Capital, founded in 1999 and headquartered in London, is a privately- owned hedge fund sponsor, funding investments in small companies, both listed and private, and real estate development opportunities.

Average round investment:6.03M USD
Average number per year:1.0
Distribution: 2021 (1)2020 (1)
Portfolio companies: United Kingdom Power RollIreland Solvotrin Therapeutics
Mostly invests in: United Kingdom United Kingdom (1) Energy (1)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to RAB Capital

Name Criteria
United Kingdom University of Bristol Enterprise Fund
79%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
Canada Vijay Pandurangan
79%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Energy, Manufacturing, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
Switzerland SchindlerAM Ventures
79%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Energy, Manufacturing, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
United Kingdom Emma Watson
79%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Energy, Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
United States Schox
79%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Energy, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
United States Wireframe Ventures
79%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Energy, Manufacturing, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
United States Refactor Capital
79%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
United States Healthspan Capital
79%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
United Kingdom University of Nottingham
79%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Energy, Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
United Kingdom Drax Group
79%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Energy, Manufacturing, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
Top